Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage

Biochemical Pharmacology

Volumn 69, Issue 4, 2005, Pages 635-640

  Mbvundula, Estery C ^a   Bunning, Rowena A D ^a   Rainsford, K D ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

Cannabinoids; Cartilage resorption; Chondrocytes; Collagen; Interleukin 1 ; Proteoglycan

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR ANTAGONIST; CYTOKINE; GLYCOSAMINOGLYCAN POLYSULFATE; NITRIC OXIDE; PROTEOGLYCAN;

ANIMAL CELL; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL METABOLISM; CHONDROLYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; DRUG EFFECT; DRUG POTENTIATION; EXPLANT; NONHUMAN; NOSE CARTILAGE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; CARTILAGE; CATTLE; CHONDROCYTES; INDOLES; INTERLEUKIN-1; MORPHOLINES; NAPHTHALENES; NITRIC OXIDE; POLYUNSATURATED ALKAMIDES; PROTEOGLYCANS; PYRAZOLES;

EID: 12744258068     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.11.018     Document Type: Article

References (35)

1. J.E. Joy S.J. Watson J.A. Benson Marijuana and medicine: assessing the science base 1999 National Academy of Sciences Washington. DC
2. S.E. Straus Immunoactive cannabinoids: therapeutic prospects for marijuana constituents Proc Natl Acad Sci USA 97 2000 9363 9364
3. F. Grotenhermen Pharmacokinetics and pharmacodynamics of cannabinoids Clin Pharmacokinet 42 2003 327 360
4. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, and W.A. Devane International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol Rev 54 2002 161 202
5. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
6. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
7. A.C. Porter, and C.C. Felder The endocannabinoid nervous system: unique opportunities for therapeutic intervention Pharmacol Ther 90 2001 45 60
8. A.C. Howlett The cannabinoid receptors Prostaglandins Other Lipid Mediat 68-69 2002 619 631
9. S.H. Burstein Ajulemic acid (CT3): a potent analog of the acid metabolites of THC Curr Pharm Des 6 2000 1339 1345
10. A.M. Malfait, R. Gallily, P.F. Sumariwalla, A.S. Malik, E. Andreakos, and R. Mechoulam The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis Proc Natl Acad Sci USA 97 2000 9561 9566
11. J. Steinmeyer, and S. Daufeldt Pharmacological influence of antirheumatic drugs on proteoglycans from interleukin-1 treated articular cartilage Biochem Pharmacol 53 1997 1627 1635
12. T. Cawston Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases Mol Med Today 4 1998 130 137
13. C.B. Little, C.E. Hughes, C.L. Curtis, M.J. Janusz, R. Bohne, and S. Wang-Weigand Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation Matrix Biol 21 2002 271 288
14. E.C. Arner, C.E. Hughes, C.P. Decicco, B. Caterson, and M.D. Tortorella Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase Osteoarthrit. Cartilage 6 1998 214 228
15. C.R. Flannery, C.B. Little, C.E. Hughes, C.L. Curtis, B. Caterson, and S.A. Jones IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage Matrix Biol 19 2000 549 553
16. E. Lubberts The role of IL-17 and family members in the pathogenesis of arthritis Curr Opin Invest Drugs 4 2003 572 577
17. T.E. Cawston, A.J. Ellis, H. Bigg, V. Curry, E. Lean, and D. Ward Interleukin-4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokines Biochim Biophys Acta 1314 1996 226 232
18. E. Lubberts, L.A. Joosten, M.M. Helsen, and W.B. van den Berg Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone Cytokine 10 1998 361 369
19. P.J. Koshy, N. Henderson, C. Logan, P.F. Life, T.E. Cawston, and A.D. Rowan Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines Ann Rheum Dis 61 2002 704 713
20. A.R. Amin, and S.B. Abramson The role of nitric oxide in articular cartilage breakdown in osteoarthritis Curr Opin Rheumatol 10 1998 263 268
21. R. Goggs, S.D. Carter, G. Schulze-Tanzil, M. Shakibaei, and A. Mobasheri Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis Vet J 166 2003 140 158
22. A.F. Mendes, A.P. Carvalho, M.M. Caramona, and M.C. Lopes Role of nitric oxide in the activation of NF-kappaB, AP-1 and NOS II expression in articular chondrocytes Inflamm Res 51 2002 369 375
23. R.K. Studer, K. Decker, S. Melhem, and H. Georgescu Nitric oxide inhibition of IGF-1 stimulated proteoglycan synthesis: role of cGMP J Orthop Res 21 2003 914 921
24. Y.E. Henrotin, P. Bruckner, and J.P. Pujol The role of reactive oxygen species in homeostasis and degradation of cartilage Osteoarthrit Cartilage 11 2003 747 755
25. D.J. Buttle, A. Fowles, M.Z. Ilic, and C.J. Handley " Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay Mol Pathol 50 1997 153 159
26. T. Mossman Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Meth 65 1983 55 63
27. 15N]nitrate in biological fluids Anal Biochem 126 1982 131 138
28. D.J. Buttle, J. Saklatvala, and A.J. Barrett The inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by cysteine endopeptidase inactivators Agents Actions Suppl 39 1993 161 165
29. R.W. Farndale, D.J. Buttle, and A.J. Barrett Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue Biochim Biophys Acta 883 1986 173 177
30. R.A. Ross, H.C. Brockie, L.A. Stevenson, V.L. Murphy, F. Templeton, and A. Makriyannis Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630 Br J Pharmacol 126 3 1999 665 672
31. S. Hashimoto, K. Takahashi, D. Amiel, R.D. Coutts, and M. Lotz Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis Arthritis Rheum 41 1998 1266 1274
32. D. Taskiran, M. Stefanovic-Racic, H. Georgescu, and C. Evans Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1 Biochem Biophys Res Commun 200 1994 142 148
33. R.M. Clancy, J. Rediske, X. Tang, N. Nijher, S. Frenkel, and M. Philips Outside-in signaling in the chondrocyte. Nitric oxide disrupts fibronectin-induced assembly of a subplasmalemmal actin/rho A/focal adhesion kinase signaling complex J Clin Invest 100 1997 1789 1796
34. R.M. Clancy, P.F. Gomez, and S.B. Abramson Nitric oxide sustains nuclear factor kappaB activation in cytokine-stimulated chondrocytes Osteoarthrit Cartilage 12 7 2004 552 558
35. E. Jimi, K. Aoki, H. Saito, F. D'Acquisto, M.J. May, and I. Nakamura Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo Nat Med 10 6 2004 617 624